• Dowd Scheffel

Law360 Publishes article Co-Authored by Matthew Dowd or Dowd Scheffel

Law360 published an article entitled “Issues to Watch In Fed. Cir. Hep C Drug Patent Case,” co-authored by Matthew Dowd and Robert Scheffel. The article discusses the case Idenix Pharmaceuticals LLC v. Gilead Sciences Inc. brought before the Federal Circuit, and summarizes the dispute, arguments raised on appeal, and potential issues that may come up at oral argument.

Featured Posts
Recent Posts
Archive

© 2020 by Dowd Scheffel PLLC.